Clinical and epidemiological evaluation of tuberculosis in Serbia, 1990-2004

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 6, 2007, Pages 647-651

  Jovanovic, D ^a   Skodric Trifunovic, V ^a   Markovic Denic, Ljiljana ^b   Stevic, R ^a   Vlajinac, H ^b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Incidence; Mortality; Serbia; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; EXTRAPULMONARY TUBERCULOSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; LABORATORY TEST; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL;

DRUG RESISTANCE, BACTERIAL; HUMANS; INCIDENCE; MASS SCREENING; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; TIME FACTORS; TUBERCULOSIS; YUGOSLAVIA;

EID: 34249887077     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Dolin P J, Raviglione M C, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-220.
2. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M C. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. JAMA 1999; 282: 677-686.
3. Raviglione M C, Pio A. Assessment of world-wide tuberculosis control 1948-2001. Lancet 2002; 359: 775-780.
4. World Health Organization. WHO tuberculosis programme: framework for effective tuberculosis control. WHO/TB/94.179. Geneva, Switzerland: WHO, 1994.
5. Raviglione M C, Rieder H L, Styblo K, Khomenko A G, Esteves J, Kochi A. Tuberculosis trends in Eastern Europe and former USSR. Tubercle Lung Dis 1994; 75: 400-416.
6. Antoine D, Maguire H, Story A. Epidemiology and response to the growing problem of tuberculosis in London. Eur Surveill 2006; 11: 25-28.
7. Espinal M A, Laszlo A, Simonsen L, et al. Global trends in resistance to anti-tuberculosis drugs. World Health Organization-International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001; 344: 1294-1304.
8. Espinal M A, Dye C. Can DOTS control multidrug-resistant tuberculosis? Lancet 2005; 365: 1209-1209.
9. Infuso A, Falzon D. World TB Day 2005: tuberculosis care providers and monitoring of treatment outcome in Europe. Euro Surveill 2005; 10: 50-53.
10. Falzon D, Desenclos J C. World TB Day: European countries report over 400 000 tuberculosis cases in 2004. Euro Surveill 2006; 11: 60-63.
11. Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367: 938-940.
12. Republican Institute of Statistics. Demographic statistics. Belgrade, Serbia: Republican Institute of Statistics, 1990-2004.
13. Serbian Institute of Pulmonary Diseases and TB, Clinical Centre. Epidemiology of lung diseases and TB in the period 1970-1996. Belgrade, Serbia: Institute of Pulmonary Diseases and TB, 1997.
14. Serbian Institute of Pulmonary Diseases and TB, Clinical Centre. Annual TB reports 1990-2004. Belgrade, Serbia: Institute of Pulmonary Diseases and TB, 2004.
15. Gledovic Z, Jovanovic M, Pekmezovic T. Tuberculosis trends in Central Serbia in the period 1956-1996. Int J Tuberc Lung Dis 2000; 4: 32-35.
16. World Health Organization. WHO report 2006. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2006.362. Geneva, Switzerland: WHO, 2006.
17. World Health Organization. Resolution WHA 44.8. Forty-fourth World Health Assembly. Resolutions and decisions. WHA44/1991/REC/1. Geneva, Switzerland: WHO, 1991.
18. National Tuberculosis Programme, Ministry of Health of Serbia. Control of tuberculosis in Serbia through the implementation of the DOTS strategy and outreach services. Belgrade, Serbia: National Tuberculosis Programme, 2003. http://www.tbc.zdravlje.sr.gov.yu/index_e.htm Accessed November 2006.
19. Skodric V. Pulmonary tuberculosis in immunocompromised host. PhD thesis. Belgrade, Serbia: University of Belgrade, Faculty of Medicine, 1996.
20. Serbian Institute of Public Health. Annual report of communicable disease in Serbia. Belgrade, Serbia: Serbian Institute of Public Health, 2006.
21. Schwoebel V, Antoine D, Veen J. Feasibility of surveillance resistance to tuberculosis drugs: Europe, 1997. Euro Surveill 2000; 5: 40-43.
22. Munsiff S S, Cook S V, Piatek A, Laraque F, Ebrahimedzadeh A, Fujiwara P I. Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003. Clin Infect Dis 2006, 42: 1702-1710.
23. Yang H, Field S K, Fisher D A, Cowie R L. Tuberculosis in Calgary, Canada, 1995-2002: site of disease and drug susceptibility. Int J Tuberc Lung Dis 2005; 9: 288-293.
24. Anonymous. Trends in tuberculosis morbidity - United States, 1992-2002, MMWR 2003; 52: 217-220, 222.
25. Garcia-Rodriquez J A, Garcia Sanchez J E, Gomes Garcia A C, Muñoz-Bellido J L. Extrapulmonary tuberculosis in a university hospital in Spain. Eur J Epidemiol 1989; 5: 154-157.
26. Cowie R L, Sharpe J W. Extra-pulmonary tuberculosis: a high frequency in the absence of HIV infection. Int J Tuberc Lung Dis 1997; 1: 159-162.